Notfälle
Blutspende
Karriere
Presse
Forschung
Lehre
Patienten
Zuweiser
Übersicht Abstracts für Kongresse 2013
| Nr. | Name des Abstracts | Autoren | Konferenz |
| 1. | Effects of RAD001 on the protein expression pattern and function of tumor and immune cells | Stehle, Schulz, Kalich, Fahldieck, Seliger | AACR 2013 USA 06.-10.04.2013 |
| 2. | Expression and function of CTLA4 in melanoma | Seliger, Wulfaenger, Biehl, Maio, Calabro, Cuaia | ASCO, Chicago, USA 31.05 – 04.06.2013 |
| 3. | Identification of proteins regulated by targeted therapies and involved in resistance to tyrosine kinase inhibitors | Stehle, Schulz, Kalich, Seliger | Proteom Forum Berlin, 17. - 20.03.2013 |
| 4. | Characterization of Hypoxia-regulated alterations in the metabolism and protein expression of tumor cells | Leisz, Stehle, Steven, Erb, Seliger | Meeting Regensburg, 25. – 27.04.2013 |
| 5. | Characterization of the altered metabolism in renal cell carcinoma | Leisz, Stehle, Schulz, Erb, Seliger | Meeting Regensburg, 25. – 27.04.2014 |
| 6. | Modulation of the immune suppressive HLA-G expression by microRNAs – a novel approach for tumor immunotherapy | Jasinski, Bukur, Massa, Spath, Hartmann, Seliger | SITC Meeting, Bethesda, USA 04. - 05.04.2013 |
| 7. | Modulation of the transcription factor CREB as a novel strategy for enhancing immunogenicity of tumor | Steven, Bukur, Massa, Seliger | SITC Meeting, Bethesda, USA 04. – 05.04.2013 |
| 8. | The link between MHC class I abnormalities of tumors, oncogenes, tumor suppressor genes and transcription factors | Barbara Seliger | CITIM Meeting, Krakow, Poland 21. – 25.04.2013 |
| 9. | Novel pathways involved in modulating antigen processing | Bukur, Gonschorek, Leisz, Mueller, Steven, Seliger | CIMT Meeting, Mainz 14. – 16.05.2013 |
| 10. | Control of non-classical HLA class I antigens by microRNAs and by RNA-binding proteins | Barbara Seliger | GRK1591, für DFG-Antrag mit Prof. Hüttelmaier |
| 11. | Modulation of microRNA by oncogenes and signal pathways involved in melanoma progression and resistances to targeted therapies | Barbara Seliger | GRK1591, für DFG-Antrag mit Prof. Hüttelmaier |
| 12. | The role of immune modulatory molecules and their regulators in human tumors | Seliger, Jasinski-Bergner, Spath, Gonschorek, Bukur, Hartmann | Cancer Immuno- therapy Meeting, New York 30.09. – 02.10.2013 |
| 13. | HLA-G-specific microRNAs a novel approach for targeting tumors | Jasinski-Bergner, Hartmann, Spath, Huettelmaier, Braun, Bukur, Seliger | SITC Meeting, Washington 07.11. – 11.11.2013 |
| 14. | Distinct strategies of melanoma to evade immune surveillance and induce resistance to targeted therapies | Barbara Seliger | Melanoma Bridge, Naples 05.12. - 08.12.2013 |
| 15. | The role of microRNA on the immune escape of human tumors | Barbara Seliger | PIVAC Meeting, Amsterdam 02.10. - 04.10.2013 |
| 16. | Immune escape of tumors controlled by transcription factors, signal transduction pathways and microRNAs | Barbara Seliger | DSC Symposium, Copenhagen 23.09. – 25.09.2013 |
| 17. | Characterization of changes within the gene expression pattern of colorectal cancer cells after nutrient depletion | Franziska Stehle and Barbara Seliger | Alterstagung, Halle/Saale, September 2013 |
| 18. | Molecular mechanisms involved in immune escape of tumors | Barbara Seliger | Annual Research Conference, Qatar 24. - 25.11.2013 |
| 19. | The role of microRNAs on tumors by shaping immune surveillance and growth properties | Seliger, Jasinski-Bergner, Bukur, Stehle | NIBIT Meeting, Siena 16.10. – 20.10.2013 |
